- Report
- March 2024
- 195 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- February 2024
- 182 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- February 2024
- 119 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- April 2023
- 150 Pages
Global
From €4689EUR$4,850USD£4,028GBP
- Report
- February 2022
- 602 Pages
Europe
From €8696EUR$8,995USD£7,470GBP
- Report
- November 2019
China
From €7729EUR$7,995USD£6,639GBP
- Report
- November 2019
Japan
From €7729EUR$7,995USD£6,639GBP
- Report
- October 2019
- 407 Pages
Brazil
From €8696EUR$8,995USD£7,470GBP
- Report
- October 2019
Australia
From €7729EUR$7,995USD£6,639GBP
- Report
- May 2021
- 36 Pages
Global
€1274EUR$1,318USD£1,094GBP
- Report
- October 2019
Brazil
From €7729EUR$7,995USD£6,639GBP
- Report
- October 2023
- 140 Pages
Global
From €2899EUR$2,999USD£2,490GBP
- Book
- July 2021
- 304 Pages
- Book
- May 2019
- 896 Pages
- Book
- September 2018
- 616 Pages
- Book
- February 2013
- 288 Pages
Prostatitis is a condition that affects the prostate gland, a small organ located near the bladder in men. It is characterized by inflammation of the prostate, which can cause pain, difficulty urinating, and other symptoms. Healthcare services for prostatitis include diagnosis, treatment, and management of the condition. Diagnosis typically involves a physical exam, laboratory tests, and imaging studies. Treatment may include antibiotics, anti-inflammatory medications, and lifestyle modifications. Management of the condition may include lifestyle changes, such as diet and exercise, and regular follow-up visits with a healthcare provider.
Companies in the prostatitis market include Astellas Pharma, Inc., Bayer AG, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer, Inc., and Sanofi S.A. Show Less Read more
